相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women
M. N. Harvie et al.
INTERNATIONAL JOURNAL OF OBESITY (2011)
Relation of B-Type Natriuretic Peptide Levels to Body Mass Index After Comprehensive Lifestyle Changes
Nita Chainani-Wu et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Effect of Weight Loss After Weight Loss Surgery on Plasma N-Terminal Pro-B-Type Natriuretic Peptide Levels
Annabel Chen-Tournoux et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
The Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide for Death and Cardiovascular Events in Healthy Normal and Stage A/B Heart Failure Subjects
Paul M. McKie et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Dynamic Cardiovascular Risk Assessment in Elderly People The Role of Repeated N-Terminal Pro-B-Type Natriuretic Peptide Testing
Christopher R. deFilippi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Body Composition and Heart Failure Prevalence and Prognosis: Getting to the Fat of the Matter in the Obesity Paradox
Carl J. Lavie et al.
MAYO CLINIC PROCEEDINGS (2010)
Association Between Direct Measures of Body Composition and Prognostic Factors in Chronic Heart Failure
Antigone Oreopoulos et al.
MAYO CLINIC PROCEEDINGS (2010)
Testosterone and type 2 diabetes
Mathis Grossmann et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2010)
Pediatric Brain Natriuretic Peptide Concentrations Vary with Age and Sex and Appear to Be Modulated by Testosterone
Amy K. Saenger et al.
CLINICAL CHEMISTRY (2009)
N-terminal pro-B-type natriuretic peptide: an independent marker for coronary artery disease in asymptomatic diabetic patients
E. Cosson et al.
DIABETIC MEDICINE (2009)
N-Terminal Pro-B-Type Natriuretic Peptide in Overweight and Obese Patients With and Without Diabetes: An Analysis Based on Body Mass Index and Left Ventricular Geometry
Seung Jei Park et al.
Korean Circulation Journal (2009)
Altered body composition in type 2 diabetes mellitus
S. Heshka et al.
INTERNATIONAL JOURNAL OF OBESITY (2008)
Biomarkers in heart failure
Eugene Braunwald
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effect of pioglitazone on heart function and N-terminal pro-brain natriuretic peptide levels of patients with type 2 diabetes
Christos Sambanis et al.
ACTA DIABETOLOGICA (2008)
Effects of rosiglitazone on plasma brain natriuretic peptide levels and myocardial performance index in patients with type 2 diabetes mellitus
Y. Tuerkmen Kemal et al.
ACTA DIABETOLOGICA (2007)
Sulfonylurea therapy is associated with increased NT-proBNP levels in the treatment of type 2 diabetes
Hugh D. Tildesley et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
Associations among androgpens, estrogems, and natriuretic peptides in young women - Observations from the Dallas Heart Study
Alice Y. Chang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide - Biomarkers for mortality in a large community-based cohort free of heart failure
PM McKie et al.
HYPERTENSION (2006)
How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure: Results from the Breathing Not Properly Multinational Study
Lori B. Daniels et al.
AMERICAN HEART JOURNAL (2006)
B-type natriuretic peptide (BNP) and N-terminal pro-BNP in obese patients without heart failure: Relationship to body mass index and gastric bypass surgery
JV St Peter et al.
CLINICAL CHEMISTRY (2006)
Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community - Determinants and detection of left ventricular dysfunction
LC Costello-Boerrigter et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease
M Richards et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Obese subjects with heart failure have lower N-terminal pro-brain natriuretic peptide plasma levels irrespective of aetiology
M Rivera et al.
EUROPEAN JOURNAL OF HEART FAILURE (2005)
Impact of body mass and body composition on circulating levels of natriuretic peptides - Results from the Dallas heart study
SR Das et al.
CIRCULATION (2005)
N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome
MH Olsen et al.
HYPERTENSION (2005)
Comparison of brain natriuretic peptide and left ventricular diastolic function determined by tissue Doppler in patients with diabetes mellitus, patients with hypertension without diabetes, and in healthy subjects
HS Lim et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Plasma N-terminal pro-brain natriuretic peptide as a major risk marker for cardiovascular disease in patients with type 2 diabetes and microalbuminuria
P Gaede et al.
DIABETOLOGIA (2005)
NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies
TA McDonagh et al.
EUROPEAN JOURNAL OF HEART FAILURE (2004)
Heart failure prevalence, incidence, and mortality in the elderly with diabetes
AG Bertoni et al.
DIABETES CARE (2004)
Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population
BA Groenning et al.
HEART (2004)
Plasma natriuretic peptide levels and the risk of cardiovascular events and death
TJ Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Impact of obesity on plasma natriuretic peptide levels
TJ Wang et al.
CIRCULATION (2004)
The incidence of congestive heart failure in type 2 diabetes
GA Nichols et al.
DIABETES CARE (2004)
Elevated plasma levels of Nt-proBNP in patients with type 2 diabetes without cardiovascular disease
M Magnusson et al.
DIABETES CARE (2004)
Obesity and suppressed B-type natriuretic peptide levels in heart failure
MR Mehra et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes
F Brancati et al.
CONTROLLED CLINICAL TRIALS (2003)
Heart failure - The frequent, forgotten, and often fatal complication of diabetes
DSH Bell
DIABETES CARE (2003)
Detection of left ventricular enlargement and impaired systolic function with plasma N-terminal pro brain natriuretic peptide concentrations
BA Groenning et al.
AMERICAN HEART JOURNAL (2002)
分享论文
